NasdaqCM - Nasdaq Real Time Price USD

Spectral AI, Inc. (MDAI)

1.2100

+0.0300

+(2.54%)

At close: April 22 at 4:00:01 PM EDT

MDAI: 2024 Results

By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) detailed 2024 financial and operational results in a March 27 th press release . Revenues of $29.6 million exceeded guidance of $28 million and our estimates of $29.3 million. Net loss was ($15.3) million or ($0.85) per share. Over the last months, Spectral has been operating at a rapid

Zacks Small Cap Research 20 days ago

MDAIW
Spectral AI (MDAI) Secures $17.7 Million to Launch Burn Wound AI System

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Spectral AI Inc. (NASDAQ:MDAI) stands against other top AI news updates investors should not miss. The global AI industry is growing at a rapid pace but a looming […]

Insider Monkey 22 days ago

MDAIW
Spectral AI Inc. (MDAI) Poised for FDA Approval with Revolutionary DeepView System

We recently published a list of 10 AI Stocks Dominating the News This Week. In this article, we are going to take a look at where Spectral AI Inc. (NASDAQ:MDAI) stands against other AI stocks dominating the news this week. Elon Musk and OpenAI have jointly proposed to fast-track their trial over OpenAI’s transition to […]

Insider Monkey 23 days ago

MDAIW
Q4 2024 Spectral AI Inc Earnings Call

Q4 2024 Spectral AI Inc Earnings Call

Thomson Reuters StreetEvents 25 days ago

MDAIW
Spectral AI Inc (MDAI) Q4 2024 Earnings Call Highlights: Record R&D Revenue and Strategic ...

Spectral AI Inc (MDAI) reports significant growth in research and development revenue, strategic deployments, and plans for FDA submission, while navigating commercial readiness challenges.

GuruFocus.com 26 days ago

MDAIW
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (“AI”) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2024”) and full year (“FY

GlobeNewswire 26 days ago

MDAI
+2.54%
MDAIW
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the successful completion of a debt financing agreement of up to $15.0 million in funding from Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, with an initial draw down of $8.5 million. In connection with

GlobeNewswire 29 days ago

MDAI
+2.54%
MDAIW
MDAI: Burn Study Topline Data

By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported topline data from its burn validation study in a March 17 th press release confirming DeepView’s superior detection sensitivity relative to burn physicians. The announcement reminded stakeholders of the device’s background and development along with a description of the burn

Zacks Small Cap Research last month

MDAIW
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that its wholly-owned subsidiary, Spectral IP, Inc., has publicly filed a registration statement with the U.S. Securities and Exchange Commission (“SEC”

GlobeNewswire last month

MDAI
+2.54%
MDAIW
Spectral AI algorithms beat physicians in burn tissue assessments

The company plans to file the results with the FDA by mid-2025 and launch the product in 2026.

MedTech Dive last month

MDAIW
Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performanceSpectral AI plans FDA submission by mid-2025, targeting De Novo Clearance and rapid commercialization to transform burn care DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, that uses multi-spectral imaging and AI algorith

GlobeNewswire last month

MDAI
+2.54%
MDAIW
Spectral AI Completes Three Device Installations in Australia

DALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of the installation of three of the DeepView System devices in Australia. The Company, in partnership with global medical device

GlobeNewswire last month

MDAI
+2.54%
MDAIW
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth quarter was incorrectly stated, and has been amended. The corrected release follows: Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and use

GlobeNewswire last month

MDAI
+2.54%
MDAIW
Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, March 27, 2025 after the close o

GlobeNewswire last month

MDAI
+2.54%
MDAIW
Spectral AI Strengthens Financial Position Ahead of FDA Submission

DALLAS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the satisfaction of its final remaining obligations under the Company’s debt facility with Yorkville Advisors. The Company retains access to addi

GlobeNewswire 2 months ago

MDAI
+2.54%
MDAIW
MDAI: Pivotal Data Analysis Complete

By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Since reporting third quarter results in November, Spectral AI, Inc. (NASDAQ:MDAI) has continued to advance its burn program in burn center populations, pediatric burn in emergency departments and with the SnapShot M portable device. Most importantly, Spectral has finished enrollment and evaluation of all patents in the burn

Zacks Small Cap Research 2 months ago

MDAIW
Spectral AI concludes burn study data analysis of DeepView system

The company anticipates submitting a De Novo request with the FDA by June.

Medical Device Network 2 months ago

MDAIW
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of its data analytics for its U.S. Burn Pivotal Study. One of the largest domestic burn studies ever conducted, the U.S. Burn Pivo

GlobeNewswire 2 months ago

MDAI
+2.54%
MDAIW
Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, today announced the completion of its pediatric enrollment at U.S. emergency departments for its U.S. Burn Pivotal Study. One of the largest domestic burn studies ever conducted, the U.S. Burn Pi

GlobeNewswire 2 months ago

MDAI
+2.54%
MDAIW
Spectral AI Provides Update to Investors

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn healing potential, today announced an update on its operating results. Pending the completion of its audited financial statements, the Company anticipates reporting annual revenue exceeding its $28 million market g

GlobeNewswire 2 months ago

MDAI
+2.54%
MDAIW

Performance Overview

Return	MDAI	S&P 500 (^GSPC)
YTD	-57.24%	-10.10%
1-Year	-33.15%	+5.53%
3-Year	-87.68%	+23.78%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Spectral AI, Inc. (MDAI)

MDAI: 2024 Results

Spectral AI (MDAI) Secures $17.7 Million to Launch Burn Wound AI System

Spectral AI Inc. (MDAI) Poised for FDA Approval with Revolutionary DeepView System

Q4 2024 Spectral AI Inc Earnings Call

Spectral AI Inc (MDAI) Q4 2024 Earnings Call Highlights: Record R&D Revenue and Strategic ...

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

MDAI: Burn Study Topline Data

Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

Spectral AI algorithms beat physicians in burn tissue assessments

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

Spectral AI Completes Three Device Installations in Australia

CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

Spectral AI Strengthens Financial Position Ahead of FDA Submission

MDAI: Pivotal Data Analysis Complete

Spectral AI concludes burn study data analysis of DeepView system

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

Spectral AI Provides Update to Investors

Performance Overview